Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
PTC Therapeutics, Inc. (NASDAQ: PTCT)
PTCT Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
7.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
28.70%
PTCT Stock Analysis
PTCT
PE Ratio:
PTCT
PEG Ratio:
PTCT
Forward EPS Growth (12 month):
160.10%
PTCT
PS Ratio:
6.9
PTCT
PSG Ratio:
0.5
PTCT
Forward Revenue Growth (12 month):
13.50%
PTCT Articles
No data was found